News

Radiologist examining a chest X-ray of a patient.

2023 Feb 08

Less Lung Tissue Removal Needed for Early-Stage Cancer, Study Finds

Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer, according to results... Read more

2023 Feb 01

Scientists Resolve a Long-Standing Mystery About mRNAs

Messenger RNAs (mRNAs) contain chemical marks that are critical for antiviral defense in cells, according to a new study from researchers at Weill Cornell Medicine. The finding solves a 50-year mystery concerning the purpose... Read more

2023 Jan 31

Weill Cornell Medicine Faculty Named AAAS Fellows

Two Weill Cornell Medicine faculty members, Dr. David Lyden , the Stavros S. Niarchos Professor in Pediatric Cardiology, and Dr. Harel Weinstein , the Maxwell M. Upson Professor of Physiology and Biophysics and past chair of... Read more

2023 Jan 30

Weill Cornell Medicine Receives NIH Grant to Improve HIV-Related Cancer Care Abroad

Weill Cornell Medicine, Moffitt Cancer Center in Tampa, Fla., and the University of North Carolina School of Medicine have received a $3.5 million, five-year grant from the National Cancer Institute (NCI), part of the... Read more

illustration of double helix and chromosomes

2023 Jan 24

Study Shows How Cells Prevent Harmful Extra DNA Copies

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers. The work , published Jan. 5 in Molecular Cell,... Read more

2023 Jan 20

Lymphoma Mutation Yields Super-Competitive Immune Cells

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells, according to a multi-... Read more

2023 Jan 10

Scientists Detail Major Mechanism Lung Cancers Use to Evade Immune Attack

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. The... Read more

2023 Jan 02

New Method Precisely Locates Gene Activity and Proteins Across Tissues

A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and... Read more

2022 Dec 30

Awards and Honors – December 30, 2022

Dr. Duncan Hau , assistant professor of clinical pediatrics, has been elected to the Association of Pediatric Program Directors ’ Global Health Learning Community Steering Committee. Committee members are global health... Read more

2022 Dec 28

Enzyme That Protects Against Viruses Could Fuel Cancer Evolution

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine... Read more

2022 Dec 15

Potential Therapy for an Aggressive Type of Colon Cancer Identified in Preclinical Studies

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators. Mesenchymal colorectal... Read more

2022 Dec 07

Weill Cornell Medicine Receives Grant to Study Effects of Radiation on Immunity

Weill Cornell Medicine has been awarded a five-year, $8.1 million grant from the National Cancer Institute of the National Institutes of Health to investigate the effects of the immune response in irradiated rectal cancer... Read more

2022 Dec 01

To Trigger Crohn’s Disease, Pathogenic Bacteria Co-opt a Genetic Susceptibility

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. These... Read more

2022 Nov 30

Awards and Honors – November 30, 2022

Dr. Erika Abramson , professor of pediatrics, has been named a member of the American Pediatric Society. Members of the society are recognized as child health leaders who work together to shape the future of academic... Read more

FOXO1 and p300 interaction demonstrated by red fluorescence.

2022 Nov 22

Discovery Suggests New Way to Target Mantle Cell Lymphoma

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this... Read more

2022 Nov 11

NIH Grant Funds Cancer Prevention Vaccine Research

A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing... Read more

2022 Oct 28

Awards and Honors – October 28, 2022

Five physicians in the Department of Radiology have been named fellows of the American College of Radiology. The recipients have been awarded based on their history of service to the college, organized radiology, teaching... Read more

2022 Oct 25

Dr. Holly Prigerson Receives NCI Award to Improve End-Stage Cancer Care

Dr. Holly G. Prigerson , the Irving Sherwood Wright Professor in Geriatrics and co-director of the Center for Research on End-of-Life Care at Weill Cornell Medicine, has been awarded a National Cancer Institute Outstanding... Read more

2022 Oct 19

Corrupt Endothelial Cells Protect Blood Cancer Cells from Chemotherapy

Endothelial cells—the cells that line blood vessels—grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found. A growing... Read more

2022 Sep 29

Fungal Association with Tumors May Predict Worse Outcomes

The presence of some fungal species in tumors predicts—and may even help drive—worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers. The study , which appears Sept. 29 in... Read more